# Enveric Biosciences, Inc.: Form 10-Q for the period ended Mar 31, 2013

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 10-Q
- Filed: 2013-05-02
- Accepted by EDGAR: May 2, 2013, 07:15 ET
- Period: 2013-03-31
- Accession: 0001477932-13-002079
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000147793213002079/spzr_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000147793213002079/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Operating income | 3 months, 2013-01-01 to 2013-03-31 | −$4.7k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2013-01-01 to 2013-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-01-01 to 2013-03-31 | −$4.7k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-01-01 to 2013-03-31 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2013-01-01 to 2013-03-31 | −$12.2k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2013-03-31 | $1.2k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-03-31 | $5.4k | us-gaap:AssetsCurrent |
| Total assets | at 2013-03-31 | $5.4k | us-gaap:Assets |
| Current liabilities | at 2013-03-31 | $30.1k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2013-03-31 | −$24.8k | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000147793213002079/spzr_10q.htm

Filed May 2, 2013.
Source: SEC EDGAR, the filing index for accession 0001477932-13-002079. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
